Impact of obesity on hospitalizations and mortality, due to COVID-19: A systematic review

[1]  L. Delgado-Roche,et al.  Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection , 2020, Archives of Medical Research.

[2]  L. Peyrin-Biroulet,et al.  Incidence and Patterns of COVID-19 Among Inflammatory Bowel Disease Patients From the Nancy and Milan Cohorts , 2020, Clinical Gastroenterology and Hepatology.

[3]  Cheng Zheng,et al.  Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China , 2020, Infection.

[4]  C. Means.  Letter to the Editor: Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy , 2020, Metabolism.

[5]  G. Muscogiuri,et al.  Commentary: Obesity: The “Achilles heel” for COVID-19? , 2020, Metabolism.

[6]  G. Mahé,et al.  Proposal of the French Society of Vascular Medicine for the prevention, diagnosis and treatment of venous thromboembolic disease in outpatients with COVID-19 , 2020, JMV-Journal de Médecine Vasculaire.

[7]  R. Arena,et al.  Respiratory Muscle Performance Screening for Infectious Disease Management Following COVID-19: A Highly Pressurized Situation , 2020, The American Journal of Medicine.

[8]  Norbert Stefan,et al.  Obesity and impaired metabolic health in patients with COVID-19 , 2020, Nature Reviews Endocrinology.

[9]  Eun Ji Kim,et al.  Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.

[10]  C. Thompson,et al.  Prevalence and Characteristics of Gastrointestinal Symptoms in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the United States: A Multicenter Cohort Study , 2020, Gastroenterology.

[11]  M. Nannipieri,et al.  Letter to the Editor: Importance of metabolic health in the era of COVID-19 , 2020, Metabolism.

[12]  M. Zheng,et al.  Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease , 2020, Metabolism.

[13]  H. Fan,et al.  Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19 , 2020, Nutrition, Metabolism and Cardiovascular Diseases.

[14]  D. Fischman,et al.  COVID-19 Complicated by Acute Pulmonary Embolism and Right-Sided Heart Failure , 2020, JACC: Case Reports.

[15]  Daniel L. Rosenfeld.  COVID-19 in the United States , 2020 .

[16]  Jason Zucker,et al.  Gastrointestinal Symptoms and Coronavirus Disease 2019: A Case-Control Study From the United States , 2020, Gastroenterology.

[17]  D. Mathieu,et al.  High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) Requiring Invasive Mechanical Ventilation , 2020, Obesity.

[18]  L. Luzi,et al.  Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic , 2020, Acta Diabetologica.

[19]  Cdc Covid- Response Team.  Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 — United States, February 12–March 28, 2020 , 2020 .

[20]  Emily N. Ussery,et al.  Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[21]  M. Puig-Domingo,et al.  COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology , 2020, Endocrine.

[22]  J. Carretero Gómez,et al.  Obesidad y coronavirus 2019nCoV: una relación de riesgo , 2020, Revista Clínica Española.

[23]  R. Muniyappa,et al.  COVID-19 pandemic, coronaviruses, and diabetes mellitus , 2020, American journal of physiology. Endocrinology and metabolism.

[24]  T. Rea,et al.  Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington , 2020, The New England journal of medicine.

[25]  Centers for Disease Control and Prevention CDC COVID-19 Response Team.  Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[26]  Yongjie Chen,et al.  The prevalence and increasing trends of overweight, general obesity, and abdominal obesity among Chinese adults: a repeated cross-sectional study , 2019, BMC Public Health.

[27]  R. Kelishadi,et al.  Health impacts of Obesity , 2014, Pakistan journal of medical sciences.

[28]  P. Cochat,et al.  Et al , 2008, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[29]  Cibele Andrucioli de Mattos Pimenta,et al.  A estratégia PICO para a construção da pergunta de pesquisa e busca de evidências , 2007 .

[30]  J. McMurray,et al.  Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew-Paisley study). , 2003, European heart journal.

[31]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[32]  Wen-Yue Liu,et al.  Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease , 2020 .

[33]  U. Bauer,et al.  [Centers for Disease Control and Prevention (CDC)]. , 2000, Annales de dermatologie et de venereologie.